LEQSELVI 8 MG Oral Tablet

RxCUI: 2716569
RxNorm name: LEQSELVI 8 MG Oral Tablet
Display name: LEQSELVI 8 MG Oral Tablet
Full name: LEQSELVI 8 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LEQSELVI	DEURUXOLITINIB PHOSPHATE	Sun Pharmaceutical Industries, Inc.	a603f231-d09e-4bad-ad5e-b55f865da095	2026-07-13	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2716569

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a603f231-d09e-4bad-ad5e-b55f865da095	LEQSELVI 8 MG Oral Tablet [PSN] · deuruxolitinib 8 MG Oral Tablet [Leqselvi] [SBD] · Leqselvi 8 MG Oral Tablet [SY]	3	11	These highlights do not include all the information needed to use LEQSELVI safely and effectively. See full prescribing information for LEQSELVI. LEQSELVI™ (deuruxolitinib) tablets, for oral use Initial U.S. Approval: 2024	20250717